154 related articles for article (PubMed ID: 2012406)
21. Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy.
Persiani R; D'Ugo D; Rausei S; Sermoneta D; Barone C; Pozzo C; Ricci R; La Torre G; Picciocchi A
J Surg Oncol; 2005 Mar; 89(4):227-36; discussion 237-8. PubMed ID: 15726615
[TBL] [Abstract][Full Text] [Related]
22. [Recurrence and survival rate of advanced gastric cancer after preoperative intraarterial EAP I injection therapy].
Takeuchi K; Taniguchi H; Miyata K; Koyama H; Tanaka H; Ueshima Y; Okano S; Oguro A; Itoh A; Sawai K
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1654-6. PubMed ID: 8373240
[TBL] [Abstract][Full Text] [Related]
23. [Neoadjuvant chemotherapy of far advanced gastric cancer--effect of preoperative chemotherapy by PMUE (CDDP, MMC, UFT, etoposide].
Kato M; Kinoshita K; Sawa T; Yoshimitsu S; Tomita F; Takano Y; Segawa M; Ohyama S; Yonemura Y; Miwa K
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):391-6. PubMed ID: 2106835
[TBL] [Abstract][Full Text] [Related]
24. [A case of gastric carcinoma with peritonitis carcinomatosa responding remarkably to etoposide, adriamycin and cisplatin (EAP) therapy].
Inaba Y; Chiba M; Watabe S; Kudo K; Hayashi K; Otsuka S
Gan To Kagaku Ryoho; 1992 Dec; 19(14):2421-3. PubMed ID: 1463349
[TBL] [Abstract][Full Text] [Related]
25. [A case of AFP (alpha-fetoprotein) producing gastric cancer successfully treated with EAP (etoposide, adriamycin, cisplatin) therapy].
Gonda T; Ishida H; Higuchi T; Hirukawa H; Nakajima H; Hojo I; Mishima Y
Gan To Kagaku Ryoho; 1994 Aug; 21(10):1659-63. PubMed ID: 7520221
[TBL] [Abstract][Full Text] [Related]
26. [Effect of preoperative THP-FLPM (pirarubicin, 5-fluorouracil, leucovorin, cisplatin, mitomycin C) therapy on far advanced gastric cancer with peritoneal dissemination].
Yano M; Tsujinaka T; Shiozaki H; Inoue M; Doki Y; Taniguchi M; Murata A; Monden M
Gan To Kagaku Ryoho; 1998 Jan; 25(1):139-42. PubMed ID: 9464342
[No Abstract] [Full Text] [Related]
27. Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer.
Hayakawa M; Morise K; Chin K; Sugihara M; Morooka Y; Maeda H; Hattori T; Saito H
Jpn J Clin Oncol; 1994 Oct; 24(5):282-8. PubMed ID: 7967107
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of TS-1 combined with cisplatin for neoadjuvant chemotherapy in patients with advanced gastric cancer].
Yabusaki H; Nashimoto A; Tanaka O
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1933-40. PubMed ID: 14650962
[TBL] [Abstract][Full Text] [Related]
29. [A gastric cancer patient with marked para-aortic lymph node metastasis surviving more than 10 years after aggressive operation and repeated EAP chemotherapy].
Uchinami M; Horiuchi T; Aotake T; Matsumura M; Yokomachi J; Tanaka K; Tabo T; Tanigawa N
Gan To Kagaku Ryoho; 2002 Mar; 29(3):449-53. PubMed ID: 11915738
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of neoadjuvant chemotherapy with paclitaxel, 5-fluorouracil and cisplatin for advanced gastric cancer with pyloric stenosis].
Yamaguchi K; Nakagawa S; Yabusaki H; Nashimoto A
Gan To Kagaku Ryoho; 2007 Dec; 34(13):2241-4. PubMed ID: 18079622
[TBL] [Abstract][Full Text] [Related]
31. [Effect of PMUE therapy (CDDP, MMC, UFT, etoposide) in terminal gastric cancer].
Sawa T; Kinoshita K; Takekawa S; Ohyama S; Hasegawa K; Fujimura T; Ueda N; Watanabe T; Kato M; Miyata T
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2381-6. PubMed ID: 2260875
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant chemotherapy, radical resection with intraoperative radiation therapy (IORT): improved treatment for gastric adenocarcinoma.
Weese JL; Harbison SP; Stiller GD; Henry DH; Fisher SA
Surgery; 2000 Oct; 128(4):564-71. PubMed ID: 11015089
[TBL] [Abstract][Full Text] [Related]
33. 7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study.
Persiani R; Rausei S; Pozzo C; Biondi A; Barone C; Cananzi FC; Schinzari G; D'Ugo D
Ann Surg Oncol; 2008 Aug; 15(8):2146-52. PubMed ID: 18543037
[TBL] [Abstract][Full Text] [Related]
34. Combination of etoposide, adriamycin and cisplatin (EAP) in gastric cancer: association with severe toxicity.
Villar-Grimalt A; Candel MT; Garcia J; Bernacer B; Jimeno J
Ann Oncol; 1991 Apr; 2(4):310-1. PubMed ID: 1868028
[No Abstract] [Full Text] [Related]
35. [Peritoneal dissemination of scirrhous type 4 gastric cancers].
Koufuji K; Aoyagi K; Yano S; Murakami N; Miyagi M; Imaizumi T; Shirouzu K
Gan To Kagaku Ryoho; 2005 Oct; 32(10):1384-8. PubMed ID: 16227734
[TBL] [Abstract][Full Text] [Related]
36. Response to neoadjuvant chemotherapy and effects of tumor regression in gastric cancer.
D'Ugo D; Persiani R; Rausei S; Biondi A; Vigorita V; Boccia S; Ricci R
Eur J Surg Oncol; 2006 Dec; 32(10):1105-9. PubMed ID: 16930932
[TBL] [Abstract][Full Text] [Related]
37. [Neoadjuvant chemotherapy for advanced gastric cancer with para-aortic lymph node metastasis].
Uehara S; Murabayashi K; Kusta T; Takahashi K; Ogawa T; Onishi H; Saegusa S; Noda N; Okanami Y; Nakamura I
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1413-8. PubMed ID: 11681249
[TBL] [Abstract][Full Text] [Related]
38. [Recurrence and survival rate of advanced gastric cancer after preoperative EAP-II intra-arterial infusion therapy].
Masuyama M; Taniguchi H; Takeuchi K; Miyata K; Koyama H; Tanaka H; Higashida T; Koishi Y; Mugitani T; Yamaguchi T
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2253-5. PubMed ID: 7944452
[TBL] [Abstract][Full Text] [Related]
39. A new schedule for etoposide, epidoxorubicin and cisplatin with granulocyte colony stimulating factor for advanced gastric cancer: a feasibility study.
Pronzato P; Vigani A; Pensa F; Botto F; Ghio E; Neri E; Tognoni A; Vaira F
Anticancer Res; 1997; 17(5B):3873-6. PubMed ID: 9427795
[TBL] [Abstract][Full Text] [Related]
40. Phase II trial of etoposide, doxorubicin (Adriamycin), and cisplatin (EAP regimen) in advanced gastric cancer.
Sparano JA; Schwartz EL; Salva KM; Pizzillo MF; Wadler S; Wiernik PH
Am J Clin Oncol; 1990 Oct; 13(5):374-8. PubMed ID: 2220657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
